G Ocak, K van Stralen, M Verduijn… - NDT …, 2011 - ndtplus.oxfordjournals.org METHODS: We assessed the mortality rates of pulmonary embolism, myocardial infarction, and stroke in dialysis patients from 11 European countries (ERA-EDTA Registry; n=120 634) and in the general population. Incident patients starting dialysis between 1995 and 2005 were ...
CK Chow, S Islam, L Bautista… - Journal of the …, 2011 - Am Coll Cardio Found A parental history (PH) of coronary heart disease (CHD) is consistently associated with a higher risk of the development of CHD in several studies (1–9). It is generally accepted that this association is explained by a combination of predominantly known risk factors and genetic variants ... Cited by 3 - Related articles - All 4 versions
DM Leistner, U Fischer-Rasokat, J Honold… - Clinical Research in …, 2011 - Springer Abstract Background Limited data is available for investigating the long-term safety and effects of intracoronary progenitor cell therapy in patients with acute myocardial infarction (AMI). Objective To assess the clinical course, NT-proBNP and MRI data as objective markers of cardiac ... Cited by 1 - Related articles - All 2 versions
C Simsek, M Magro, E Boersma… - The Journal of …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Short- and long-term data showed that drug-eluting stents (DES) significantly decreased target vessel revascularization (TVR) and major adverse cardiac event (MACE) rates compared to bare-metal stents (BMS). However, conflicting long-term data remain for ... Cited by 1
[HTML] from jacccardiovascularinterventions.comC Spaulding, E Teiger, P Commeau… - JACC …, 2011 - interventions.onlinejacc.org Background: Concern over the safety of drug-eluting stents implanted during PCI for STEMI remains, and long-term follow-up from randomized trials are necessary. TYPHOON (Trial to assess the use of the cYPHer sirolimus-eluting stent in acute myocardial infarction treated with ... Cited by 5 - Related articles - All 4 versions